Table 2.
Changes in malaria indicators from 2013 to 2014 at surveyed health facilities, stratified by time and zone
Ebola-unaffected prefectures from 2013 to 2014 |
Ebola-affected prefectures from 2013 to 2014 |
||||||
---|---|---|---|---|---|---|---|
January to March | April to July | August to November | January to March | April to July | August to November | ||
Adults and children (age ≥5 years) | |||||||
All-cause patient visits | 5% | 10% | −6% | 10% | −22% | −42% | |
Fever cases | −2% | 12% | −16% | −2% | −32% | −46% | |
Tested for malaria | 73% | 80% | 23% | 32% | −9% | −23% | |
Confirmed cases of malaria | 72% | 75% | 36% | 32% | −21% | −35% | |
Treated with oral antimalarial drugs | −13% | 8% | −21% | −21% | −42% | −58% | |
Treated with injectable antimalarial drugs | −12% | 21% | −17% | −40% | −44% | −69% | |
Children (age <5 years) | |||||||
All-cause patient visits | 7% | 18% | −17% | −16% | −9% | −17% | |
Fever cases | 9% | 18% | −21% | −4% | −17% | −24% | |
Tested for malaria | 63% | 77% | 27% | 37% | 20% | 7% | |
Confirmed cases of malaria | 54% | 57% | 39% | 22% | 26% | 0% | |
Treated with oral antimalarial drugs | −4% | 15% | −19% | −8% | −19% | −35% | |
Treated with injectable antimalarial drugs | −22% | −24% | −28% | −25% | −24% | −62% | |
Pregnant women | |||||||
Antenatal visits | 4% | 9% | 14% | 4% | 6% | −26% | |
Doses of sulfadoxine-pyrimethamine given during antenatal clinic visits | 28% | 33% | 15% | 37% | 59% | 37% |
Numbers used to calculate the percentage changes are reported in the appendix.